358 related articles for article (PubMed ID: 21040674)
1. [Localization diagnostics of neuroendocrine gastrointestinal tumours].
Kjaer A; Knigge U; Mortensen J; Hansen CP; Fallentin E
Ugeskr Laeger; 2010 Oct; 172(43):2953-6. PubMed ID: 21040674
[TBL] [Abstract][Full Text] [Related]
2. Guidelines for the management of gastroenteropancreatic neuroendocrine (including carcinoid) tumours.
Ramage JK; Davies AH; Ardill J; Bax N; Caplin M; Grossman A; Hawkins R; McNicol AM; Reed N; Sutton R; Thakker R; Aylwin S; Breen D; Britton K; Buchanan K; Corrie P; Gillams A; Lewington V; McCance D; Meeran K; Watkinson A;
Gut; 2005 Jun; 54 Suppl 4(Suppl 4):iv1-16. PubMed ID: 15888809
[No Abstract] [Full Text] [Related]
3. [Neuroendocrine tumours of pancreas and gastrointestinal tract].
Tsimmerman IaS
Klin Med (Mosk); 2009; 87(12):7-13. PubMed ID: 20135878
[TBL] [Abstract][Full Text] [Related]
4. Nordic Guidelines 2010 for diagnosis and treatment of gastroenteropancreatic neuroendocrine tumours.
Janson ET; Sørbye H; Welin S; Federspiel B; Grønbaek H; Hellman P; Mathisen O; Mortensen J; Sundin A; Thiis-Evensen E; Välimäki MJ; Oberg K; Knigge U
Acta Oncol; 2010 Aug; 49(6):740-56. PubMed ID: 20553100
[TBL] [Abstract][Full Text] [Related]
5. Somatostatin receptor scintigraphy with 111In-pentetreotide in non-functioning gastroenteropancreatic neuroendocrine tumors.
Schillaci O; Spanu A; Scopinaro F; Falchi A; Corleto V; Danieli R; Marongiu P; Pisu N; Madeddu G; Delle Fave G; Madeddu G
Int J Oncol; 2003 Dec; 23(6):1687-95. PubMed ID: 14612942
[TBL] [Abstract][Full Text] [Related]
6. [Imaging of neuroendocrine tumors of the pancreas].
Vick C; Zech CJ; Höpfner S; Waggershauser T; Reiser M
Radiologe; 2003 Apr; 43(4):293-300. PubMed ID: 12721645
[TBL] [Abstract][Full Text] [Related]
7. Imaging of neuroendocrine tumours (CT/MR/US).
Rockall AG; Reznek RH
Best Pract Res Clin Endocrinol Metab; 2007 Mar; 21(1):43-68. PubMed ID: 17382265
[TBL] [Abstract][Full Text] [Related]
8. [Expert dialogue: neuroendocrine tumours of the lungs and gastroenteropancreatic system].
Hörsch D; Sayeg Y; Bonnet R; Kaemmerer D; Presselt N; Baum RP
Pneumologie; 2012 Jan; 66(1):44-8. PubMed ID: 22250054
[TBL] [Abstract][Full Text] [Related]
9. [Neuroendocrine tumours of the gastrointestinal tract].
Plöckinger U; Wiedenmann B
Z Gastroenterol; 2004 Jun; 42(6):517-27. PubMed ID: 15190448
[TBL] [Abstract][Full Text] [Related]
10. [Imaging methods in diagnosis of neuroendocrine tumors of the gastrointestinal tract].
Zimmer T; Faiss S; Buhr HJ; Hamm B; Wiedenmann B
Bildgebung; 1995 Mar; 62(1):5-13. PubMed ID: 7756824
[TBL] [Abstract][Full Text] [Related]
11. [Neuroendocrine tumours of the upper gastrointestinal tract, characteristics and comparison of localization diagnostics].
Hyrdel R; Reznák I; Hyrdel P; Polácek H; Polácek H; Hladká M; Agouba SM; Janík J; Laca L
Vnitr Lek; 2011 Dec; 57(12):1017-24. PubMed ID: 22277035
[TBL] [Abstract][Full Text] [Related]
12. [Primary hyperparathyroidism, adrenal tumors and neuroendocrine tumors of the pancreas--clinical diagnosis and imaging requirements].
Auernhammer CJ; Engelhardt D; Göke B
Radiologe; 2003 Apr; 43(4):265-74. PubMed ID: 12721642
[TBL] [Abstract][Full Text] [Related]
13. [Polish diagnostic and therapeutic guidelines in gastroenteropancreatic neuroendocrine tumors (GEP NET)].
Kos-Kudła B;
Endokrynol Pol; 2006; 57(3):267-72. PubMed ID: 17111342
[No Abstract] [Full Text] [Related]
14. Diagnostic uses of radiolabelled somatostatin receptor analogues in gastroenteropancreatic endocrine tumours.
Gibril F; Jensen RT
Dig Liver Dis; 2004 Feb; 36 Suppl 1():S106-20. PubMed ID: 15077919
[TBL] [Abstract][Full Text] [Related]
15. Guidelines for the management of gastroenteropancreatic neuroendocrine tumours (including bronchopulmonary and thymic neoplasms). Part I-general overview.
Oberg K; Astrup L; Eriksson B; Falkmer SE; Falkmer UG; Gustafsen J; Haglund C; Knigge U; Vatn MH; Välimäki M;
Acta Oncol; 2004; 43(7):617-25. PubMed ID: 15545182
[TBL] [Abstract][Full Text] [Related]
16. Biology, diagnosis, and treatment of neuroendocrine tumors of the gastrointestinal tract.
Oberg K
Curr Opin Oncol; 1994 Jul; 6(4):441-51. PubMed ID: 7803546
[TBL] [Abstract][Full Text] [Related]
17. Neuroendocrine tumour management: a team approach.
Banfield A; Green S; Ramage JK
Hosp Med; 2005 Jan; 66(1):37-42. PubMed ID: 15686165
[TBL] [Abstract][Full Text] [Related]
18. Therapeutic monitoring of gastroenteropancreatic neuroendocrine tumors: the challenges ahead.
Sundin A; Rockall A
Neuroendocrinology; 2012; 96(4):261-71. PubMed ID: 22907438
[TBL] [Abstract][Full Text] [Related]
19. Current Concepts in the Management of GEP-NETs: Introduction.
Iyer R
Clin Adv Hematol Oncol; 2016 Apr; 14(4 Suppl 6):3-4. PubMed ID: 27167990
[No Abstract] [Full Text] [Related]
20. Diagnosis of non-functioning neuro-endocrine gastro-enteropancreatic tumours.
Plöckinger U; Wiedenmann B
Neuroendocrinology; 2004; 80 Suppl 1():35-8. PubMed ID: 15477715
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
